Johnson & Johnson launches new coronary IVL catheter that cuts treatment times in half
Johnson & Johnson MedTech has launched its new coronary intravascular lithotripsy (IVL) catheter in the United States, making the next-generation device available to customers ahead of TCT 2026 in San Diego.
The Shockwave C2 Aero Fly Coronary IVL Catheter represents the latest edition to Johnson & Johnson MedTech’s Shockwave C2 Aero portfolio, giving clinicians another tool for treating calcified coronary plaques prior to percutaneous coronary intervention procedures. The newly launched device delivers pulses twice as fast as previous offerings, and balloon inflation time has been minimized. In addition, the pause time between pulsing cycles has been cut in half, dropping from 10 seconds all the way to five seconds.
“Shockwave C2 Aero Fly is built for the future of coronary interventions, where physicians need proven technologies that can help them move faster without compromising safety or confidence in challenging calcified cases,” Mike Lang, worldwide president of circulatory restoration for Johnson & Johnson MedTech, said in a statement. “As the pioneer and leader of the category, Johnson & Johnson is giving physicians and patients an increasingly efficient, predictable platform designed to meet the growing demands of complex coronary care.”
“In the cath lab, every second matters, especially as we see more complex cases and higher procedure volumes,” added Hector Tamez Aguilar, MD, an interventional cardiologist at Piedmont Healthcare in Atlanta, Georgia. “By delivering pulses twice as fast and decreasing pause time between cycles, Shockwave C2 Aero Fly enables faster workflows, helping physicians treat calcified coronary disease more efficiently while meeting the growing pace and demand of cath labs.”
Another step forward for an IVL pioneer
Shockwave Medical was a pioneer in the field of IVL, developing new treatments for patients presenting with calcified coronary artery disease. In 2024, Johnson & Johnson acquired Shockwave Medical for approximately $13 billion. The company still went by the name Shockwave Medical for the next few years, but it is now officially known as a part of Johnson & Johnson MedTech.
The Shockwave C2 Aero Fly Coronary IVL Catheter will be on display inside Johnson & Johnson MedTech’s booth at TCT 2026 in San Diego Oct. 31-Nov. 3.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.